Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04225208 · ClinicalTrials.gov registry record · Phase 1
Pharmacokinetic and Mass Balance Study of Orally Administered [14C]-AZD4205 in Healthy Adult Male Volunteers
A Phase 1 study of Healthy Volunteers, sponsored by Dizal Pharmaceuticals.
- Completed
- Registry status
- Phase 1
- Development phase
- 8
- Enrollment target
- 1
- Study location
NCT04225208: Completed Phase 1 study of Healthy Volunteers, sponsored by Dizal Pharmaceuticals.
NCT04225208 is a Phase 1 study of Healthy Volunteers that has completed, run by Dizal Pharmaceuticals. The registered enrollment target is 8 participants, below the 482-participant average among 283 other Healthy Volunteers trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04225208, a Phase 1 study of Healthy Volunteers, has completed, sponsored by Dizal Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 8 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a phase I, open label, healthy volunteers, ADME study with single oral administration of \[14C\]-AZD4205.
Primary Outcome
To evaluate the percentage of radioactive dose of \[14C\] radiolabelled AZD4205 recovered in urine, feces, and in total
Conditions Studied
Interventions
- DRUG [14C]-AZD4205, single 50 mg oral dose administrated on day 1
Study Locations (1)
Maryland
- Pharmaron CPC - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2020-01-06 |
| Est. Completion | 2020-03-02 |
| Phase | Phase 1 |
What the finished NCT04225208 record still lists
NCT04225208 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 8 participants, a relatively small participant target, below the 482-participant average among 283 other Healthy Volunteers trials with a reported enrollment target (98% lower).
The record links to 1 condition, with Healthy Volunteers appearing as the primary indexed condition, and to 1 intervention - of which [14C]-AZD4205, single 50 mg oral dose administrated on day 1 is the first listed.
NCT04225208 reports a single indexed study location in Maryland.
Frequently Asked Questions
What is clinical trial NCT04225208 about?
NCT04225208 is a clinical study titled "Pharmacokinetic and Mass Balance Study of Orally Administered [14C]-AZD4205 in Healthy Adult Male Volunteers". This is a phase I, open label, healthy volunteers, ADME study with single oral administration of \[14C\]-AZD4205.
What is the current status of trial NCT04225208?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 8 participants. The study started on 2020-01-06. Estimated completion is 2020-03-02.
What conditions does trial NCT04225208 study?
This clinical trial studies the following conditions: Healthy Volunteers.
What interventions are being tested in trial NCT04225208?
The interventions under investigation include: [14C]-AZD4205, single 50 mg oral dose administrated on day 1 (DRUG).
Who is sponsoring clinical trial NCT04225208?
This trial is sponsored by Dizal Pharmaceuticals, which has 15 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04225208 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Healthy Volunteers
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04225208's enrollment target sits among peer trials
8 269th of 283 higher than 7 of 283 other Healthy Volunteers trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Healthy Volunteers trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Research Study to Evaluate the Safety of NNC4004-0002 When Given to Participants With Asymptomatic Hyperuricemia
RECRUITING · Phase 1
-
A Phase 1 Study to Evaluate the Safety and Pharmacokinetics of ABBV-243 in Healthy Adults.
RECRUITING · Phase 1
-
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Immunogenicity of ABBV-277 in Healthy Adult Participants
RECRUITING · Phase 1
-
A Study to Evaluate the Effect of Single Oral Dose of Balinatunfib on Cardiac Repolarization in Healthy Adult Participants.
RECRUITING · Phase 1
-
Classroom Break, Cognition, and Fitness in Elementary School Children
RECRUITING · Phase 1
-
A Study to Assess the Relative Bioavailability of BMS-986435 and Food Effect on the BMS-986435 in Healthy Adult Participants
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI